All terms in GO

Label Id Description
negative regulation of thyroid-stimulating hormone secretion GO_2000613 [Any process that stops, prevents or reduces the frequency, rate or extent of thyroid-stimulating hormone secretion.]
negative regulation of peptide hormone secretion GO_0090278 [Any process that decreases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.]
negative regulation of thyroid hormone generation GO_2000610 [Any process that stops, prevents or reduces the frequency, rate or extent of thyroid hormone generation.]
negative regulation of hormone metabolic process GO_0032351 [Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving any hormone.]
positive regulation of thyroid hormone generation GO_2000611 [Any process that activates or increases the frequency, rate or extent of thyroid hormone generation.]
obsolete negative regulation of histone H3-K9 acetylation GO_2000616 [OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 acetylation.]
obsolete positive regulation of histone H3-K9 acetylation GO_2000617 [OBSOLETE. Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.]
positive regulation of thyroid-stimulating hormone secretion GO_2000614 [Any process that activates or increases the frequency, rate or extent of thyroid-stimulating hormone secretion.]
positive regulation of peptide hormone secretion GO_0090277 [Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.]
obsolete regulation of histone H3-K9 acetylation GO_2000615 [OBSOLETE. Any process that modulates the frequency, rate or extent of histone H3-K9 acetylation.]
beta-L-Ara4N-lipid A biosynthetic process GO_1901760 [The chemical reactions and pathways resulting in the formation of beta-L-Ara4N-lipid A which occurs as a result of modification of the lipid A moiety of lipopolysaccharide by the addition of the sugar 4-amino-4-deoxy-L-arabinose (L-Ara4N). This strategy is adopted by pathogenic Gram-negative bacteria to evade cationic antimicrobial peptides produced by the innate immune system.]
oxytetracycline metabolic process GO_1901761 [The chemical reactions and pathways involving oxytetracycline.]
oxytetracycline catabolic process GO_1901762 [The chemical reactions and pathways resulting in the breakdown of oxytetracycline.]
oxytetracycline biosynthetic process GO_1901763 [The chemical reactions and pathways resulting in the formation of oxytetracycline.]
phosphinothricin metabolic process GO_1901764 [The chemical reactions and pathways involving phosphinothricin.]
phosphinothricin catabolic process GO_1901765 [The chemical reactions and pathways resulting in the breakdown of phosphinothricin.]
phosphinothricin biosynthetic process GO_1901766 [The chemical reactions and pathways resulting in the formation of phosphinothricin.]
carbapenem metabolic process GO_1901767 [The chemical reactions and pathways involving carbapenem.]
carbapenem catabolic process GO_1901768 [The chemical reactions and pathways resulting in the breakdown of carbapenem.]
carbapenem biosynthetic process GO_1901769 [The chemical reactions and pathways resulting in the formation of carbapenem.]